Nataliya V. Uboha

1.5k total citations
69 papers, 588 citations indexed

About

Nataliya V. Uboha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nataliya V. Uboha has authored 69 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Nataliya V. Uboha's work include Gastric Cancer Management and Outcomes (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Nataliya V. Uboha is often cited by papers focused on Gastric Cancer Management and Outcomes (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Nataliya V. Uboha collaborates with scholars based in United States, United Kingdom and Spain. Nataliya V. Uboha's co-authors include Marina R. Picciotto, Angus C. Nairn, Sam Joseph Lubner, Marc Flajolet, Howard S. Höchster, Noelle K. LoConte, Kristina A. Matkowskyj, Dustin A. Deming, Monica Patel and Jeremy D. Kratz and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Cancer.

In The Last Decade

Nataliya V. Uboha

58 papers receiving 573 citations

Peers

Countries citing papers authored by Nataliya V. Uboha

Since Specialization

Citations

This map shows the geographic impact of Nataliya V. Uboha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataliya V. Uboha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataliya V. Uboha more than expected).

Fields of papers citing papers by Nataliya V. Uboha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nataliya V. Uboha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataliya V. Uboha. The network helps show where Nataliya V. Uboha may publish in the future.

Co-authorship network of co-authors of Nataliya V. Uboha

This figure shows the co-authorship network connecting the top 25 collaborators of Nataliya V. Uboha. A scholar is included among the top collaborators of Nataliya V. Uboha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nataliya V. Uboha. Nataliya V. Uboha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer 2025 ·Journal of Surgical Oncology ·Nataliya V. Uboha, (unknown), Jens C. Eickhoff, Dustin A. Deming, Kristina A. Matkowskyj, James D. Maloney, Daniel McCarthy, Malcolm M. DeCamp, Noelle K. LoConte, Philip B. Emmerich, (unknown), Monica Patel, Jeremy D. Kratz, Sam Joseph Lubner, (unknown), M. Bassetti	0
2	QUIC: Phase 2 study of gemcitabine, cisplatin, quemliclustat (AB680), and zimberelimab (AB122) during first-line treatment of advanced biliary tract cancers (BTC)—Big Ten Cancer Research Consortium study BTCRC-GI22-564. 2024 ·Journal of Clinical Oncology ·J. Ebben, Jens C. Eickhoff, Dustin A. Deming, Howard S. Höchster, Anita Turk, Vaibhav Sahai, Nataliya V. Uboha	1
3	Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer 2024 ·Cancer Discovery ·Rona Yaeger, Nataliya V. Uboha, (unknown), Tanios Bekaii‐Saab, Minal Barve, Joel Saltzman, Joshua K. Sabari, Julio A. Peguero, Andrew Scott Paulson, Pasi A. Jänne, Marcia Cruz‐Correa, Kenna Anderes, Karen Velastegui, Xiaohong Yan, Hirak Der‐Torossian, Samuel J. Klempner, Scott Kopetz	44
4	Phase IA/IB Study of OAR-Based, Dose-Escalated SBRT with Real Time Adaptive MRI Guidance for Liver Metastases: Preliminary Safety and Efficacy Results 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Jacob S. Witt, (unknown), Stephen A. Rosenberg, Carri Glide‐Hurst, Joy Crosby, (unknown), (unknown), (unknown), (unknown), Matthias Weiss, (unknown), Nataliya V. Uboha, (unknown)	1
5	Actionable molecular alterations in veterans with advanced cholangiocarcinoma. 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), Colin P. Bergstrom, (unknown), Noelle K. LoConte, Sam Joseph Lubner, Kristina A. Matkowskyj, Monica Patel, Sean M. Ronnekleiv‐Kelly, Nataliya V. Uboha, Megan Wachsmann, David H. Wang, Albert Y. Lin, Jeremy D. Kratz	1
6	Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression 2024 ·JCI Insight ·Xingchen Dong, Ming Qi, (unknown), (unknown), (unknown), Sally Coulter, (unknown), Christopher Liddle, Nataliya V. Uboha, Richard B. Halberg, Wei Xu, Paul C. Marker, Ting Fu	18
7	Precision of liver and pancreas apparent diffusion coefficients using motion-compensated gradient waveforms in DWI 2024 ·Magnetic Resonance Imaging ·Jitka Starekova, (unknown), Zihan Wang, Yuxin Zhang, Nataliya V. Uboha, Ali Pirasteh, Diego Hernando	0
8	549O Adagrasib with or without cetuximab in patients with KRASG12C-mutated colorectal cancer (CRC): Analysis of tumor biomarkers and genomic alterations 2023 ·Annals of Oncology ·(unknown), (unknown), (unknown), S-H.I. Ou, Alexander I. Spira, Pasi A. Jänne, Nataliya V. Uboha, Yousuf Gaffar, (unknown), Cloud P. Paweletz, (unknown), (unknown), Thian Kheoh, Kenna Anderes, (unknown), (unknown), (unknown)	5
9	Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges 2023 ·Pathology - Research and Practice ·Min Cui, (unknown), Zhicheng Jin, Nataliya V. Uboha	3
10	Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis 2021 ·Journal of Gastrointestinal Oncology ·(unknown), Timothy J. Ziemlewicz, Sam Joseph Lubner, (unknown), Sharon M. Weber, (unknown), Colin A. Longhurst, J. Louis Hinshaw, Meghan G. Lubner, Daniel Mulkerin, Daniel E. Abbott, Dustin A. Deming, Noelle K. LoConte, Nataliya V. Uboha, (unknown), Shane A. Wells, Paul F. Laeseke, (unknown), Fred T. Lee	17
11	Treatment Approach to Adenocarcinoma of the Ampulla of Vater 2021 ·Current Treatment Options in Oncology ·Monica Patel, Nataliya V. Uboha	9
12	A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Jacob S. Witt, (unknown), Meghan G. Lubner, Scott B. Reeder, Steve Y. Cho, Rebecca M. Minter, Sharon M. Weber, Sean M. Ronnekleiv‐Kelly, Daniel E. Abbott, Noelle K. LoConte, Daniel Mulkerin, Sam Joseph Lubner, Nataliya V. Uboha, Dustin A. Deming, Mark A. Ritter, Pranshu Mohindra, M. Bassetti	8
13	Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma 2020 ·Translational Gastroenterology and Hepatology ·(unknown), Nataliya V. Uboha, Vanessa L. Horner, (unknown), Kristina A. Matkowskyj	34
14	Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors 2020 ·Investigational New Drugs ·Nataliya V. Uboha, Sam Joseph Lubner, Noelle K. LoConte, Daniel Mulkerin, Jens C. Eickhoff, Dustin A. Deming	4
15	Metastatic Bulk Independently Predicts Outcomes for EGFR Precision Targeting in Colorectal Cancer 2018 ·Journal of the National Comprehensive Cancer Network ·Jeremy D. Kratz, Nataliya V. Uboha, Sam Joseph Lubner, Daniel Mulkerin, Linda Clipson, (unknown), Menggang Yu, Kristina A. Matkowskyj, Noelle K. LoConte, Dustin A. Deming	5
16	Adjuvant Chemotherapy for Stage II Rectal Cancer 2015 ·Seminars in Oncology ·Dustin A. Deming, Nataliya V. Uboha, S. Yousuf Zafar, Stephen A. Rosenberg, M. Bassetti, Sean C. Glasgow, Ernest C. Borden, Sam Joseph Lubner	2
17	Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer 2014 ·Cancer Chemotherapy and Pharmacology ·Howard S. Höchster, Nataliya V. Uboha, Wells A. Messersmith, Philip J. Gold, Bert H. O’Neil, Deirdre Jill Cohen, Crystal S. Denlinger, S. Cohen, Cynthia G. Leichman, Lawrence Leichman	30
18	A Calcium- and Calmodulin-Dependent Kinase Iα/Microtubule Affinity Regulating Kinase 2 Signaling Cascade Mediates Calcium-Dependent Neurite Outgrowth 2007 ·Journal of Neuroscience ·Nataliya V. Uboha, Marc Flajolet, Angus C. Nairn, Marina R. Picciotto	59
19	Expression of ezrin in glial tubes in the adult subventricular zone and rostral migratory stream 2006 ·Neuroscience ·Maureen Cleary, Nataliya V. Uboha, Marina R. Picciotto, Robert D. Beech	19
20	Cytoplasmic localization of calcium/calmodulin‐dependent protein kinase I‐α depends on a nuclear export signal in its regulatory domain 2004 ·FEBS Letters ·(unknown), Nataliya V. Uboha, Timothy T. Stedman, Angus C. Nairn, Marina R. Picciotto	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact